Commentaires de nos clients
Votre panier
€ 0.00 (0 articles)
Search:
Perform search
Liste des catégories

Générique Bicalutamide - Casodex

News
Recherche par lettre:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Casodex
Casodex Générique est utilisé pour traiter le cancer de la prostate. Ce médicament est destiné à être utilisé avec d'autres médicaments.
€ 3.64
Bookmarks sociaux
Pays, langue et monnaie


Remboursementgaranti
Achatsécurisé

Notre page de facturation est certifiée par:

Secure shopping certificates

Special Offer!

  • La seduta del Consiglio regionale del 15 maggio 2012 - completo - Regione Liguria

    La seduta del Consiglio regionale del 15 maggio 2012 - completoRegione LiguriaPellerano aggiunge che «il bicalutamide 'CASODEX' è il farmaco originale mentre uno dei farmaci generici con lo stesso principio attivo è il bicalutamide 'HIKMA'».

  • INTERROGAZIONE DI PELLERANO SUI FARMACI CONTRO I TUMORI DELLA PROSTATA. LA ... - Liguria Notizie

    INTERROGAZIONE DI PELLERANO SUI FARMACI CONTRO I TUMORI DELLA PROSTATA.

  • MDVN Misses; Focus on Enzalutamide - Zacks.com

    MDVN Misses; Focus on EnzalutamideZacks.

  • Medivation Reports First Quarter Financial Results and Provides Corporate Update - MarketWatch (press release)

    Medivation Reports First Quarter Financial Results and Provides Corporate UpdateMarketWatch (press release)Continued to enroll patients in the Phase 2 TERRAIN trial, which is comparing the effect of enzalutamide versus bicalutamide, the most commonly used anti-androgen, on progression-free survival in approximately 370 men with advanced prostate cancer who .

  • New Therapies for Prostate Cancer: The Practicalities - OncLive

    OncLiveNew Therapies for Prostate Cancer: The PracticalitiesOncLive12,13 This investigational agent is an irreversible androgen receptor (AR) antagonist and AR signaling inhibitor, and represents an advance from the nonsteroidal AR antagonists flutamide, bicalutamide, and nilutamide.

    Copyright © www.drugsengine.com is an affiliate marketing website. Tous droits réservés.